Applying science to care.

Medavera identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content, and then utilizes a format that will provide the best learning opportunity. We are always looking for new teaching methods and technologies in order to offer stimulating and actionable medical education. Medical education must be meaningful to become applied to clinical practice. Great content, respected leaders, and interesting formats create successful interactions and learning.
FEATURED PROJECT

Hyperphosphatemia in CKD: Cases for Improving Compliance and Outcome
September 13, 2016
5 PM ET

KidneyU.com

This accredited educational webinar presented by Drs. Ellie Kelepouris, Kathleen Hill Gallant, and Debra J. Hain, will explore hyperphosphatemia in CKD patients, compare and contrast new phosphate binders, and identify new strategies to improve patient adherence and outcome for CKD patients with hyperphosphatemia.

Planned and developed by Medavera, financial support for this independent medical education program was provided by Keryx Biopharmaceuticals, Inc.

There is no charge for the program or certificate, but registration is required for the webinar, access to the slides, and CME assessment.

THE MEDICAL NEWS
BANGKOK (Reuters) - Thailand is investigating four suspected cases of Zika-related microcephaly in three babies and a 36-week old unborn baby, the public health minister said on Tuesday, in what could be the first cases of Zika-linked microcephaly in Southeast Asia.... (Reuters) - Bristol-Myers Squibb Co said on Tuesday it would evaluate the use of its blockbuster cancer immunotherapy Opdivo in combination with an experimental drug from Nektar Therapeutics to treat multiple cancers.... (Reuters Health) - Giving stimulants to kids with attention deficit hyperactivity disorder (ADHD) may not help them complete homework or get better grades, a small study suggests.... (Reuters) - Amgen Inc said on Tuesday its multiple myeloma drug, Kyprolis, did not fare better than Takeda Pharmaceutical Co Ltd's older therapy Velcade in a study involving patients who had not yet been treated for the disease.... (Reuters Health) - When little kids need to get a painful injection, music therapy can help them get through the procedure, a new study suggests.... NEW YORK (Thomson Reuters Foundation) - The Americas has become the first region in the world to be free of measles, following a 22-year vaccination drive against the disease which continues to infect tens of thousands of people globally, the Pan American Health Organization said on Tuesday.... (Reuters Health) - Patients who get tattoos to cover facial skin grafts and scars may feel happier with both their appearance and quality of life, a Dutch study suggests.... (Reuters Health) - Pregnant women should get routine blood pressure checks at every prenatal visit to screen for preeclampsia, according to new proposed U.S. guidelines aimed at preventing deaths from this complication.... (Reuters Health) - Portrayals of brain death in film and television are as fictional as the characters, researchers say.... Sanofi SA said on Monday the U.S. Department of Health and Human Services (HHS) approved $43.18 million in funding to accelerate the development of a Zika vaccine, as efforts to prevent the infection gather momentum....